Abstract
Cytarabine (AraC) is an essential chemotherapeutic for acute myeloid leukemia (AML) and resistance to this drug is a major cause of treatment failure. AraC is a nucleoside analog that differs from 2′-deoxycytidine only by the presence of an additional hydroxyl group at the C2′ position of the 2′-deoxyribose. The active form of the drug AraC 5′-triphosphate (AraCTP) is utilized by human replicative DNA polymerases to insert AraC at the 3′ terminus of a growing DNA chain. This impedes further primer extension and is a primary basis for the drug action. The Y-family translesion synthesis (TLS) DNA polymerase η (Polη) counteracts this barrier to DNA replication by efficient extension from AraC-terminated primers. Here, we provide high-resolution structures of human Polη with AraC incorporated at the 3′-primer terminus. We show that Polη can accommodate AraC at different stages of the catalytic cycle, and that it can manipulate the conformation of the AraC sugar via specific hydrogen bonding and stacking interactions. Taken together, the structures provide a basis for the ability of Polη to extend DNA synthesis from AraC terminated primers.
Similar content being viewed by others
Introduction
Cytarabine (1-β-D-arabinofuranosylcytosine, AraC) has been the mainstay therapy for acute myeloid leukemia (AML) for over 40 years1,2,3. Resistance to cytarabine is a major cause of treatment failure and only ~27% of adult patients survive more than 5 years after the initial diagnosis4. AraC is a nucleoside analog that differs from 2′-deoxycytidine only by the presence of an additional hydroxyl group at the C2′ position of the 2′-deoxyribose (Fig. 1). This 2′-OH of the arabinose sugar moiety points in an opposite direction to that of the 2′-OH of the ribose sugar in ribonucleotides (Fig. 1).
AraC is a prodrug, which after entering the cell is phosphorylated by deoxycytidine and pyrimidine kinases to its active form, AraC 5′-triphosphate (AraCTP)5. AraC kills cells undergoing DNA synthesis in the S-phase of the cell cycle and its chemotherapeutic action is primarily associated with DNA fragmentation and chain termination5. Concordantly, high-fidelity replicative DNA polymerases α, δ and ε that replicate the bulk of genomic DNA in eukaryotes6,7 can proficiently insert AraC at the 3′ terminus of a growing DNA chain but the subsequent extension reaction is markedly impeded8,9,10,11. Nevertheless, a substantial fraction of AraC-terminated primers do get extended12, and thereby reducing the effectiveness of the chemotherapy. This has been attributed to specialized, lower fidelity translesion DNA synthesis (TLS) polymerases, which allow for the continuity of the replication fork by allowing replication through modified DNA bases that impede the high-fidelity replicative polymerase7,13. TLS polymerase η (Polη) stands out in that human cells deficient in Polη are ~3-fold more sensitive to AraC than wild-type cells and the polymerase can efficiently extend AraC-terminated primers in vitro14.
To see how Polη can extend AraC-terminated primers we present here high-resolution crystal structures of human Polη in binary and ternary complexes with AraC. We show that Polη can accommodate AraC at different stages of the catalytic cycle, and that it can manipulate the conformation of the AraC sugar via specific hydrogen bonding and stacking interactions. Taken together, the structures provide an unexpected basis for the ability of Polη to extend DNA synthesis from AraC terminated primers.
Results
Biochemical Analysis
We first carried out biochemical analysis to compare the ability of human Polη to extend DNA synthesis from an unmodified C and AraC 3′-terminated DNA primers. As shown in Fig. 2A (lane 2), with a 5′-…CCTAAGA…-3′ DNA template (5′-GTCTAATACTTCCTAAGATGCCTACACTGGAGTACCGGA-3′), elongation from unmodified C paired with the cognate template G base results in nearly complete extension to the full products in 10 min of the reaction time. A slightly lesser amount of the extension products is observed with the AraC-terminated primer (Fig. 2A, lane 3). Likewise, with a 5′-…GGGGGGA…-3′ DNA template that contains six consecutive G residues, extension from the 3′-terminal unmodified C or AraC opposite the first G of the template strand results in the nearly complete products (Fig. 2B, lanes 2 and 3). We conducted primer elongation on the G-repeat template in the presence of all four dNTPs with the unmodified primer, whereas, with the AraC-terminated primer, we used AraCTP, dATP, dGTP and dTTP nucleotides. Thus, the efficient formation of the fully extended products (Fig. 2B, lane 3) suggest that Polη can not only extend from a single AraC residue but also can consequently incorporate and extend from it to create a run of AraC bases. Overall, our results demonstrate that Polη is proficient in extension from AraC-terminated primers in various sequence contexts and are in accord with previous observations14.
Structure determination
We crystalized the human Polη catalytic core (residues 1 to 432) with a DNA 12-nucleotide (nt) template (5′-CATGACAGTGCT-3′)/8-nt primer (5′-AGCACTGT-3′) and AraCTP. However, when we solved the structure and refined it to 1.83 Å resolution, we discovered that despite the suboptimal reaction conditions in the crystallization drop (low pH 6.0 and presence of Ca2+ ions) Polη had covalently added the AraC residue to the 3′ end of the primer strand. This represents a “post-insertion” binary complex in which polymerase has not yet translocated to the next templating position. To capture the polymerase in the act of inserting dNTP from an AraC terminated primer, we first incubated the polymerase with a 12-nt template (5′-CATTGCAGTGCT-3′)/7-nt primer (5′-AGCACTG-3′) and AraCTP at pH 8.0 and in the presence of Mg2+ to incorporate AraC at the primer terminus, followed by removal of unincorporated AraCTP, and then addition of nonreactive dATP analog dAMPNPP (2′-deoxyadenosine-5′-[(α,β)-imido]triphosphate) to the crystallization mix. This represents a ternary complex in which AraC is incorporated at 3′ end of the primer and dAMPNPP is the incoming nucleotide. The structure was refined to high 1.75 Å resolution and provides atomic details on the conformation of AraC and its interactions with the polymerase. The crystal data, data collection statistics, and refinement statistics for both complexes are summarized in Table 1.
Overall Arrangement
In both complexes (Figs 3A and 4A), Polη embraces the template–primer with its palm (residues 1–13 and 90–238), fingers (residues 17–87), thumb (residues 241–301) domains and the PAD (polymerase associated domain or the little finger domain; residues 319–432) that is unique to Y-family polymerases. The palm domain provides the catalytic residues Asp13, Asp115, and Glu116, while the fingers domain is positioned above the templating base. The thumb and the PAD grip the template–primer DNA duplex from the minor and major groove surfaces, respectively (Figs 3A and 4A).
Binary complex
AraC is covalently incorporated into the primer strand and its base makes a normal Watson-Crick base pair with a template G. The sugar of AraC stacks against the planar phenyl ring of Phe18 in the fingers domain (Fig. 3B,C). Phe18 occurs at a position in common with an aromatic residue in many other DNA polymerases, functioning as a “steric gate” for discrimination against the insertion of ribonucleotides (NTPs). That is, the orientation of 2′-OH on a NTP sugar is such that it would clash with the aromatic residue and the NTP would be excluded from incorporation. Because the 2′-OH on an AraC sugar points in an opposite direction to that on an NTP sugar, it does not generate any steric clashes and provides a basis by which Polη can incorporate AraCTP but not an NTP into a growing DNA chain. AraC is further stabilized in the Polη active site by a hydrogen bond between its 3′-OH and the backbone N atom of Phe17 (Fig. 3C).
Interestingly, the conformation of AraC sugar is C3′-endo (Fig. 3C,D). This was a surprise because an A-form RNA-like C3′-endo sugar pucker is considered unfavorable for an arabinonucleoside15,16,17. However, the C3′-endo conformation is stabilized in the Polη active site by a hydrogen bond and stacking interactions with Arg61, a residue unique to Polη. In addition, there is a direct hydrogen bond between 2′-OH of the AraC sugar and the main chain carbonyl of Ile48. Together, these interactions facilitate and stabilize the C3′-endo pucker even though it is unfavorable for an arabinonucleoside. Overall, it further supports the idea that DNA polymerases in general mold DNA into an A-form-like conformation at the primer terminus18,19,20,21,22,23,24,25,26.
Ternary complex
The ternary complex provides a basis for the addition of dNTP from an AraC primer terminus. As expected, 1) AraC has incorporated at the 3′ end of the primer strand, 2) the polymerase has translocated to the next templating position, and 3) the dATP nonreactive analog dAMPNPP has entered the active site (Fig. 4A–C). The dAMPNPP sugar is juxtaposed against the phenyl ring of Phe18, and two Mg2+ ions (A and B) complete the active site. MgA2+ is ligated by the α-phosphate of dAMPNPP, the carboxylates of Asp115 (2.55 Ả) and Glu116 (2.22 Ả), and a water molecule (Fig. 4B). MgB2+ is coordinated in the basal octahedral plane by the dAMPNPP β- and γ-phosphates, the carboxylates of Asp13 (2.15 Ả) and Asp115 (2.08 Ả) and by the backbone carboxyl oxygen of Met14 (2.25 Ả). Thus, the overall configuration of the active site is very similar to that observed in previous Polη ternary complexes with unmodified DNAs and nonreactive dNTP analogs27, except that the 3′-OH of the AraC primer terminus is shifted by ~1.1 Å compared to the unmodified structures and is now too far away to interact with MgA2+. This small shift of the 3′-OH is due to a slight tilt of the AraC sugar moiety (Fig. 3D). Hence, the χ torsion angle around the N-glycosidic bond that connects the base to the sugar (O4′-C1′-N1-C2) is changed from −115.0° in the unmodified 3′ primer T residue to −149.2° in the 3′ primer AraC. The altered position of the 3′-OH of AraC might underlie the slightly lower efficiency in Polη-catalyzed extension from AraC 3′-terminus relative to the unmodified primer base.
Compared to the binary complex, the AraC sugar at the primer terminus has switched to the normal for DNA B-form C2′-endo conformation (Figs 4B,C). It appears to be driven into this conformation by a direct hydrogen bond between 2′-OH of the AraC sugar and the non-bridging oxygen atom of the α-phosphate of dAMPNPP. Thus, in the C2′-endo conformation, the AraC sugar plays a direct role in binding of the incoming nucleotide. The 2′-OH of AraC sugar is also involved in a water-mediated hydrogen bond with Arg61. This has the effect of stabilizing Arg61 into a single rotameric conformation, as compared to multiple conformations of Arg61 in Polη ternary complex with unmodified primer terminus and nonreactive dNTP analogs (Fig. 4D)27.
Discussion
Polη is currently the only known human DNA polymerase capable of efficiently extending DNA synthesis from an AraC–terminated primer. We show here that AraC is stabilized in the Polη active site via specific hydrogen bonding and stacking interactions. By contrast, human X-family polymerases Polλ and Polβ that function in base excision repair (BER) can insert AraC in a gapped DNA substrate, but there is no evidence to suggest that these polymerases can extend DNA synthesis from AraC-terminated primers28,29.
Interestingly, a time-resolved crystallographic study of Polη’s catalytic cycle has revealed that the deoxyribose sugar of the 3′-terminal primer base changes its conformation from C2′-endo to C3′-endo during the phosphoryl transfer reaction30. This is apparently necessary to avoid clashes with the non-bridging oxygen of incoming nucleotide. We envisage a similar C2′-endo to C3′-endo transition of the AraC sugar during the catalytic reaction. Indeed, when we superimpose the C3′-endo AraC sugar (observed in our binary complex) onto the penultimate primer base in the time resolved structure (PDB ID: 4ECX, 300 sec reaction time)30 (Fig. 5), the “extra” 2′-OH on the AraC sugar is not only accommodated without any steric overlap, but can potentially make hydrogen bonds with the phosphate group and adenine base of the incorporated nucleotide (Fig. 5). Whether this creates sequence bias or mutagenic incorporation of purines during the extension of AraC remains to be determined.
Overall, the ability of the arabinose sugar in AraC to adopt or transition to the C3′-endo pucker is surprising. This is because the sugar in AraC (and other arabinonucleosides) is considered relatively restricted in conformation and preferentially adopts the C2′-endo16 or C1′-exo17 puckers. However, we show that this conformational restriction is easily surmounted in the Polη active site by interactions that 2′-OH of the C3′-endo sugar is able to establish with the polymerase. It would be interesting to know whether a more “rigid” sugar in AraC reduces the ability of Polη to extend DNA synthesis: lending to increased efficacy in the treatment of AML. In particular, locked conformation nucleotide analog chemistry may be helpful in the design and synthesis of such conformationally restricted AraC-like analogs31.
Methods
Preparation of protein and DNA for crystallization
An N-terminal His6 tagged catalytic core of human Polη (residues 1–432) with a C406M mutation was overexpressed in Escherichia coli and purified as previously described27,32. Briefly, the His6 tag was removed by overnight incubation with PreScission protease, and the protein was purified by ion-exchange (MonoS) chromatography followed by size-exclusion (Superdex 75). The protein was concentrated to ~1.3 mg/ml in 25 mM tris (pH 8.0), 250 mM NaCl, and 2 mM tris(2-carboxyethyl) phosphate (TCEP) and stored in aliquots at −80 °C.
Crystallization
The crystals of the post-insertion AraC binary complex were obtained by incubating the human Polη catalytic core with a template-primer (5′-CATGACAGTGCT-3′/5′-AGCACTGT-3′) (Glen Research, Inc) in the presence of AraCTP (TriLink Biotechnologies inc.) by the hanging drop method against a reservoir solution containing 0.1 M MES pH 6.0 buffer and 10–14% PEG1500. Briefly, the template-primer DNAs were annealed and mixed with Polη in a 1.2:1 molar ratio to ~0.02 mM concentration of the complex in 25 mM tris (pH 8.0), 125 mM NaCl and 1 mM TCEP. The complex was concentrated with Amicon Ultra centrifugal filter (cut-off 3KDa) to a final complex concentration of ~0.105 mM. AraCTP and CaCl2 were then added to the complex to 2 mM and 4 mM concentrations, respectively. The complex was centrifuged at 8,000 rpm for 2 min at 4 °C. Crystallization drop was formed by mixing 1 μL of the complex with 1 μL of the reservoir solution and the crystals were grown at 20 °C. (The AraC residue was covalently added to the 3′ end of the primer strand under these conditions). A round of microseeding was necessary to produce larger diffraction-quality crystals. The crystals were cryoprotected in the reservoir solution supplemented with 24% PEG1500 and, sequentially, with 5%, 10% and 20% glycerol and flash frozen in liquid nitrogen for X-ray data collection.
To crystallize the extension ternary complex we prepared the binary polymerase complex with 12-nt template (5′-CATTGCAGTGCT-3′)/7-nt primer (5′-AGCACTG-3′) DNA as described above. We than added 2 mM AraCTP with 5 mM MgCl2 and incubated the reaction for 20 min at 16 °C. Following removal of the unincorporated AraCTP with Amicon Ultra centrifugal filter, we added a nonreactive dATP analog dAMPNPP (2′-deoxyadenosine-5′-[(α,β)-imido]triphosphate) at 2 mM and 5 mM MgCl2. The crystals were grown as described for the post-insertion binary complex.
Structure determination and refinement
The X-ray diffraction data were collected at the NSLS X25 beam line at the Brookhaven National Laboratory and at the 24-ID NE-CAT beamline at Advanced Photon Source in Chicago. The data from the NSLS X25 beam line were processed and scaled using the HKL2000 suite33 and the data from the 24-ID NE-CAT beamline were processed by RAPD pipeline (http://necat.chem.cornell.edu/). We solved the structure by the molecular replacement method (Phaser)34 in the CCP4 program package35 using the Polη postinsertion binary complex structure (PDB ID: 4J9P) as a search model36. The model building, including substitution of the DNA sequence, was finished manually in Coot37 based on the electron density maps calculated in PHENIX Refine38. The final model was refined in PHENIX Refine38 and belongs to P61 space group with unit cell dimensions of a = b = 98.6 Å, c = 81.5 Å, α = β = 90°, and γ = 120.0°. The structure has been refined to 1.83 Å resolution with Rfree of 19.6% and Rwork of 16.0% and consists of one Polη molecule (residues 1 to 432), one DNA template (residues 2 to 12), one DNA primer (residues 1 to 9), and a total of 436 solvent molecules. The placement of the AraC residue was verified using simulated annealing omit maps calculated in PHENIX38 with the AraC omitted from the model before heating to 2,000 K and then slowly cooling.
We solved the structure of the AraC-modified extension ternary complex by MR using the structure of Polη ternary complex (PDB ID 3MR2)27 as a search model. We refined the model as described above to 1.75 Å resolution in P61 space group with unit cell dimensions of a = b = 98.8 Å, c = 81.8 Å, α = β = 90°, and γ = 120.0°; with Rfree of 19.6% and Rwork of 16.8%. The model consists of one Polη molecule (residues 1 to 432), one DNA template (residues 2 to 12), one DNA primer (residues 1 to 8), one dAMPNPP, two Mg2+ ions and a total of 383 solvent molecules.
The crystal data, together with the data collection and refinement statistics, are summarized in Table 1.
Primer extension
We used two different DNA templates, G1 and G6, to examine extension from a C or AraC paired with an unmodified template G. The G1 template oligonucleotide contains the sequence 5′-GTCTAATACTTCCTAAGATGCCTACACTGGAGTACCGGA-3′. The G6 template oligonucleotide contains a run of 6 G residues and it has the sequence 5′-GTCTAATACTTGGGGGGATGCCTACACTGGAGTACCGGA-3′. We employed the 5′-32P labeled 23 nt primers 5′-TCCGGTACTCCAGTGTAGGCATX-3′ where X is a C or an AraC. Thus, DNA substrates for primer extension consisted of a 32P-radiolabeled oligonucleotide primer (23 nt) annealed to a 39 nt oligonucleotide DNA template by heating a mixture of primer/template at a 1:1.5 molar ratio to 95 °C and allowing it to cool to room temperature for several hours. The standard DNA polymerase reaction (5 μl) contained 25 mM tris (pH 7.5), 5 mM MgCl2, 1 mM dithiothreitol, 100 μg/ml BSA, 10% glycerol, 10 nM DNA substrate, and 1 nM of Polη. Primer extension was assayed at 37 °C for 10 min in the presence of 25 μM of dATP, dGTP, and dTTP for G1 template and 50 μM each of dATP, dGTP, dTTP and dCTP (Roche Biochemicals, Indianapolis) for extension from C and 50 μM each of dATP, dGTP, dTTP and araCTP for extension from AraC on G6 template DNA. Reactions were stopped by the addition of loading buffer (95% formamide, 0.05% cyanol blue and 0.05% bromophenol blue) and the reaction products were than resolved on a 12% polyacrylamide gel containing 8 M urea. Gels were dried before autoradiography with a PhosphorImager.
Data availability
Atomic coordinates and structure factors have been deposited deposited in the Protein Data Bank under accession codes 6D0M and 6D0Z for the AraC post-insertion binary and extension ternary complexes, respectively.
References
Magina, K. N. et al. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood 130, 946–948, https://doi.org/10.1182/blood-2017-04-777722 (2017).
Kadia, T. M., Ravandi, F., O’Brien, S., Cortes, J. & Kantarjian, H. M. Progress in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk 15, 139–151, https://doi.org/10.1016/j.clml.2014.08.006 (2015).
Lichtman, M. A. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7 + 3. Blood Cells Mol Dis 50, 119–130, https://doi.org/10.1016/j.bcmd.2012.10.005 (2013).
Cancer Facts and Figures 2017. American Cancer Society (2017).
Grant, S. Ara-C: cellular and molecular pharmacology. Adv Cancer Res 72, 197–233 (1998).
Lujan, S. A., Williams, J. S. & Kunkel, T. A. DNA Polymerases Divide the Labor of Genome Replication. Trends Cell Biol 26, 640–654, https://doi.org/10.1016/j.tcb.2016.04.012 (2016).
Jain, R., Aggarwal, A. K. & Rechkoblit, O. Eukaryotic DNA polymerases. Current Opinion in Structural Biology 53, 77–87 (2018).
Mikita, T. & Beardsley, G. P. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry 27, 4698–4705 (1988).
Perrino, F. W. & Mekosh, H. L. Incorporation of cytosine arabinoside monophosphate into DNA at internucleotide linkages by human DNA polymerase alpha. J Biol Chem 267, 23043–23051 (1992).
Perrino, F. W., Mazur, D. J., Ward, H. & Harvey, S. Exonucleases and the incorporation of aranucleotides into DNA. Cell Biochem Biophys 30, 331–352, https://doi.org/10.1007/BF02738118 (1999).
Tsuda, M. et al. The dominant role of proofreading exonuclease activity of replicative polymerase epsilon in cellular tolerance to cytarabine (Ara-C). Oncotarget 8, 33457–33474, https://doi.org/10.18632/oncotarget.16508 (2017).
Major, P. P., Egan, E. M., Herrick, D. J. & Kufe, D. W. Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells. Biochem Pharmacol 31, 2937–2940 (1982).
Prakash, S., Johnson, R. E. & Prakash, L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 74, 317–353, https://doi.org/10.1146/annurev.biochem.74.082803.133250 (2005).
Chen, Y. W., Cleaver, J. E., Hanaoka, F., Chang, C. F. & Chou, K. M. A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res 4, 257–265, https://doi.org/10.1158/1541-7786.MCR-05-0118 (2006).
Teng, M. K., Liaw, Y. C., van der Marel, G. A., van Boom, J. H. & Wang, A. H. Effects of the O2′ hydroxyl group on Z-DNA conformation: structure of Z-RNA and (araC)-[Z-DNA]. Biochemistry 28, 4923–4928 (1989).
Gmeiner, W. H., Konerding, D. & James, T. L. Effect of cytarabine on the NMR structure of a model okazaki fragment from the SV40 genome. Biochemistry 38, 1166–1175, https://doi.org/10.1021/bi981702s (1999).
Li, F. et al. 2′-Fluoroarabino- and arabinonucleic acid show different conformations, resulting in deviating RNA affinities and processing of their heteroduplexes with RNA by RNase H. Biochemistry 45, 4141–4152, https://doi.org/10.1021/bi052322r (2006).
Doublie, S., Tabor, S., Long, A. M., Richardson, C. C. & Ellenberger, T. Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature 391, 251–258, https://doi.org/10.1038/34593 (1998).
Li, Y., Korolev, S. & Waksman, G. Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation. EMBO J 17, 7514–7525, https://doi.org/10.1093/emboj/17.24.7514 (1998).
Franklin, M. C., Wang, J. & Steitz, T. A. Structure of the replicating complex of a pol alpha family DNA polymerase. Cell 105, 657–667 (2001).
Johnson, S. J., Taylor, J. S. & Beese, L. S. Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations. Proc Natl Acad Sci USA 100, 3895–3900, https://doi.org/10.1073/pnas.0630532100 (2003).
Batra, V. K. et al. Magnesium-induced assembly of a complete DNA polymerase catalytic complex. Structure 14, 757–766, https://doi.org/10.1016/j.str.2006.01.011 (2006).
Berman, A. J. et al. Structures of phi29 DNA polymerase complexed with substrate: the mechanism of translocation in B-family polymerases. EMBO J 26, 3494–3505, https://doi.org/10.1038/sj.emboj.7601780 (2007).
Garcia-Diaz, M., Bebenek, K., Krahn, J. M., Pedersen, L. C. & Kunkel, T. A. Role of the catalytic metal during polymerization by DNA polymerase lambda. DNA Repair (Amst) 6, 1333–1340, https://doi.org/10.1016/j.dnarep.2007.03.005 (2007).
Wang, F. & Yang, W. Structural Insight into Translesion Synthesis by DNA Pol II. Cell 139, 1279–1289, https://doi.org/10.1016/j.cell.2009.11.043 (2009).
Swan, M. K., Johnson, R. E., Prakash, L., Prakash, S. & Aggarwal, A. K. Structural basis of high-fidelity DNA synthesis by yeast DNA polymerase delta. Nat Struct Mol Biol 16, 979–986, https://doi.org/10.1038/nsmb.1663 (2009).
Biertumpfel, C. et al. Structure and mechanism of human DNA polymerase eta. Nature 465, 1044–1048, https://doi.org/10.1038/nature09196 (2010).
Chrencik, J. E., Burgin, A. B., Pommier, Y., Stewart, L. & Redinbo, M. R. Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex. J Biol Chem 278, 12461–12466, https://doi.org/10.1074/jbc.M212930200 (2003).
Prakasha Gowda, A. S., Polizzi, J. M., Eckert, K. A. & Spratt, T. E. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry 49, 4833–4840, https://doi.org/10.1021/bi100200c (2010).
Nakamura, T., Zhao, Y., Yamagata, Y., Hua, Y. J. & Yang, W. Watching DNA polymerase eta make a phosphodiester bond. Nature 487, 196–201, https://doi.org/10.1038/nature11181 (2012).
Singh, S. K., Nielsen, P., Koshkin, A. A. & Wengel, J. LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem Commun, 455-456, https://doi.org/10.1039/a708608c (1998).
Ummat, A. et al. Structural basis for cisplatin DNA damage tolerance by human polymerase eta during cancer chemotherapy. Nat Struct Mol Biol 19, 628–632, https://doi.org/10.1038/nsmb.2295 (2012).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307–326 (1997).
McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658–674, https://doi.org/10.1107/S0021889807021206 (2007).
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235–242, https://doi.org/10.1107/S0907444910045749 (2011).
Zhao, Y. et al. Mechanism of somatic hypermutation at the WA motif by human DNA polymerase eta. Proc Natl Acad Sci USA 110, 8146–8151, https://doi.org/10.1073/pnas.1303126110 (2013).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–2132, https://doi.org/10.1107/S0907444904019158 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213–221, https://doi.org/10.1107/S0907444909052925 (2010).
Acknowledgements
We thank the staff at beam lines X25 at the Brookhaven National Laboratory and Northeastern Collaborative Access Team (NECAT) at the Argonne National Laboratory for facilitating x-ray data collection. This work was supported by NIH grant R01 CA200575. The NECAT beamline was funded by the National Institute of General Medical Sciences (NIGMS) from the NIH (P41 GM103403). The Pilatus 6 M detector on 24-ID-C beamline was funded by an NIH–Office of Research Infrastructure Programs High-End Instrumentation grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.
Author information
Authors and Affiliations
Contributions
O.R., S.P. and A.K.A. designed the experiments. A.B. performed protein expression and purification. O.R. performed crystallization, X-ray data collection and refinement; J.R.C. performed primer extension experiments under supervision of S.P. and L.P.; O.R. and A.K.A. wrote the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rechkoblit, O., Choudhury, J.R., Buku, A. et al. Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine. Sci Rep 8, 12702 (2018). https://doi.org/10.1038/s41598-018-30796-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-30796-w
This article is cited by
-
Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η
Scientific Reports (2022)
-
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
BMC Cancer (2020)
-
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η
Scientific Reports (2019)
-
Multifaceted activities of DNA polymerase η: beyond translesion DNA synthesis
Current Genetics (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.